thioctic acid has been researched along with Abdominal Migraine in 5 studies
Thioctic Acid: An octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nutraceuticals like alpha-lipoic acid (ALA) may have potential benefits as prophylactic agents for adolescent migraine, with fewer adverse events than existing medications." | 3.30 | Evaluation of Safety and Efficacy of Add-on Alpha-Lipoic Acid on Migraine Prophylaxis in an Adolescent Population: A Randomized Controlled Trial. ( Jena, M; Maiti, R; Mishra, BR; Puliappadamb, HM; Satpathy, AK, 2023) |
| "In total, 92 women with episodic migraine participated in the study." | 3.01 | The efficacy of alpha-lipoic acid in improving oxidative, inflammatory, and mood status in women with episodic migraine in a randomised, double-blind, placebo-controlled clinical trial. ( Alavi Naeini, A; Askari, G; Heidari, Z; Khorvash, F; Rezaei Kelishadi, M, 2021) |
| "Five Belgian centers recruited 54 migraineurs (43 migraine without aura, 11 with aura; mean age 38 +/- 8 years; 7 males)." | 2.73 | A randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis. ( Ambrosini, A; Jacquy, J; Laloux, P; Magis, D; Sándor, P; Schoenen, J, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kelishadi, MR | 1 |
| Naeini, AA | 1 |
| Khorvash, F | 2 |
| Askari, G | 2 |
| Heidari, Z | 2 |
| Puliappadamb, HM | 1 |
| Satpathy, AK | 1 |
| Mishra, BR | 1 |
| Maiti, R | 1 |
| Jena, M | 1 |
| Rezaei Kelishadi, M | 1 |
| Alavi Naeini, A | 1 |
| Brenner, SR | 1 |
| Magis, D | 1 |
| Ambrosini, A | 1 |
| Sándor, P | 1 |
| Jacquy, J | 1 |
| Laloux, P | 1 |
| Schoenen, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Double-blinded, Placebo-controlled Trial of Idebenone in the Prevention of Episodic Migraine[NCT04151472] | Phase 3 | 180 participants (Anticipated) | Interventional | 2021-12-08 | Recruiting | ||
| Evaluation of Efficacy and Safety of add-on Alpha-lipoic Acid on Migraine Prophylaxis in Adolescent Population: A Randomized Controlled Trial[NCT04064814] | Phase 4 | 60 participants (Actual) | Interventional | 2019-09-14 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for thioctic acid and Abdominal Migraine
| Article | Year |
|---|---|
The beneficial effect of Alpha-lipoic acid supplementation as a potential adjunct treatment in episodic migraines.
Topics: Adult; Dietary Supplements; Double-Blind Method; Female; Humans; Iran; Lactic Acid; Migraine Disorde | 2022 |
Evaluation of Safety and Efficacy of Add-on Alpha-Lipoic Acid on Migraine Prophylaxis in an Adolescent Population: A Randomized Controlled Trial.
Topics: Adolescent; Analgesics; Calcitonin Gene-Related Peptide; Child; Double-Blind Method; Flunarizine; Hu | 2023 |
The efficacy of alpha-lipoic acid in improving oxidative, inflammatory, and mood status in women with episodic migraine in a randomised, double-blind, placebo-controlled clinical trial.
Topics: Antioxidants; Biomarkers; C-Reactive Protein; Dietary Supplements; Double-Blind Method; Female; Huma | 2021 |
A randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis.
Topics: Adult; Belgium; Double-Blind Method; Energy Metabolism; Female; Humans; Male; Middle Aged; Migraine | 2007 |
1 other study available for thioctic acid and Abdominal Migraine
| Article | Year |
|---|---|
Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs.
Topics: Brain Diseases, Metabolic; Chronic Disease; Disease Progression; DNA, Mitochondrial; Genetic Predisp | 2010 |